SciSparc Advances with FDA Approval on Phase IIb Clinical Trial for Tourette Syndrome Therapy
Sep 30, 2024
Fda Investment Portfolios
Organon Expands Dermatology Portfolio with Acquisition of Dermavant's VTAMA® Cream
Sep 19, 2024
Apple's AirPods Pro 2 Acquire FDA Clearance for Advanced Hearing Aid Features
Sep 14, 2024
Mainz Biomed Shares Surge on FDA Submission News Amid Pre-Market Moves
Jul 10, 2024
Glenmark Pharma Secures USFDA Approval for Heartburn Medicine
Jun 12, 2024
BDX's FDA-Approved HPV Test to Expand Women's Health Screening Accessibility
May 18, 2024
FDA Approves IMDelltra™ (Tarlatamab-DLLe), a Novel T-Cell Engager Therapy for Extensive-Stage Small Cell Lung Cancer
May 17, 2024
Incannex Healthcare Announces Successful Pre-IND Meeting with FDA for Opioid Use Disorder Treatment
May 7, 2024
Aquestive Therapeutics Announces 2023 Financial Outcomes and Updates on Business Progress
Mar 6, 2024
FDA Warns Against Non-Invasive Glucose-Monitoring Smart Devices
Feb 23, 2024
Incannex's Groundbreaking CannQuit-N Moves Forward After Positive Pre-IND Meeting with the FDA
Feb 17, 2024
FDA Panel Advocates for Increased Diversity in Pulse Oximeter Clinical Trials
Feb 4, 2024
Novartis Enhances Radiotherapy Arsenal with State-of-the-Art Manufacturing Facility for Pluvicto™ in Indianapolis
Jan 6, 2024
Ipsen Announces FDA's Priority Review of Elafibranor for PBC Treatment, with EMA Also Validating MAA
Dec 7, 2023
Sernova Corp Receives FDA Orphan Drug and Rare Pediatric Disease Designations for Hemophilia A Treatment
Nov 27, 2023
SciSparc's SCI-110 Shows Promise in Phase IIb Trial for Tourette Syndrome
Nov 13, 2023